Cargando…

Quality of care for patients evaluated for tuberculosis in the context of Xpert MTB/RIF scale-up

RATIONALE: Many high-burden countries are scaling-up Xpert MTB/RIF using a hub-and-spoke model. We evaluated the quality of care for patients undergoing TB evaluation at microscopy centers (spokes) linked to Xpert testing sites (hubs) in Uganda. OBJECTIVES: To characterize the extent to which patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farr, Katherine, Nalugwa, Talemwa, Ojok, Christopher, Nantale, Mariam, Nabwire, Sarah, Oyuku, Denis, Shete, Priya B., Han, Alvina H., Fielding, Katherine, Joloba, Moses, Mugabe, Frank, Dowdy, David W., Moore, DAJ, Davis, J. Lucian, Katamba, Achilles, Cattamanchi, Adithya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830152/ https://www.ncbi.nlm.nih.gov/pubmed/31720425 http://dx.doi.org/10.1016/j.jctube.2019.100099

Ejemplares similares

Challenges with scale-up of GeneXpert MTB/RIF® in Uganda: a health systems perspective
por: Nalugwa, Talemwa, et al.
Publicado: (2020)

Feasibility of a short message service (SMS) intervention to deliver tuberculosis testing results in peri-urban and rural Uganda
por: Babirye, Diana, et al.
Publicado: (2019)

Implementation of Xpert MTB/RIF in Uganda: Missed Opportunities to Improve Diagnosis of Tuberculosis
por: Hanrahan, Colleen F., et al.
Publicado: (2016)

Population-Level Impact of Same-Day Microscopy and Xpert MTB/RIF for Tuberculosis Diagnosis in Africa
por: Dowdy, David W., et al.
Publicado: (2013)

Readiness to implement on-site molecular testing for tuberculosis in community health centers in Uganda
por: Nalugwa, Talemwa, et al.
Publicado: (2022)

Study protocol: a cluster randomized trial to evaluate the effectiveness and implementation of onsite GeneXpert testing at community health centers in Uganda (XPEL-TB)
por: Reza, Tania F., et al.
Publicado: (2020)

Empiric treatment of pulmonary TB in the Xpert era: Correspondence of sputum culture, Xpert MTB/RIF, and clinical diagnoses
por: Kendall, Emily A., et al.
Publicado: (2019)

Where will it end? Pathways to care and catastrophic costs following negative TB evaluation in Uganda
por: Samuels, Thomas H. A., et al.
Publicado: (2021)

Design and execution of a public randomization ceremony to enhance stakeholder engagement within a cluster randomized trial to improve tuberculosis diagnosis in Uganda
por: Reza, Tania F., et al.
Publicado: (2021)

Feasibility of a multifaceted intervention to improve treatment initiation among patients diagnosed with TB using Xpert MTB/RIF testing in Uganda
por: Zawedde-Muyanja, Stella, et al.
Publicado: (2022)

Patient and health system factors associated with pretreatment loss to follow up among patients diagnosed with tuberculosis using Xpert® MTB/RIF testing in Uganda
por: Zawedde-Muyanja, Stella, et al.
Publicado: (2020)

Evaluating the impact of cash transfers on tuberculosis (ExaCT TB): a stepped wedge cluster randomised controlled trial
por: Shete, Priya B., et al.
Publicado: (2023)

Multicomponent strategy with decentralised molecular testing for tuberculosis in Uganda: a cost and cost-effectiveness analysis
por: Thompson, Ryan R, et al.
Publicado: (2023)

Sputum quality and diagnostic performance of GeneXpert MTB/RIF among smear-negative adults with presumed tuberculosis in Uganda
por: Meyer, Amanda J., et al.
Publicado: (2017)

Feasibility of a streamlined tuberculosis diagnosis and treatment initiation strategy
por: Shete, P. B., et al.
Publicado: (2017)

Accuracy of different Xpert MTB/Rif implementation strategies in programmatic settings at the regional referral hospitals in Uganda: Evidence for country wide roll out
por: Muttamba, Winters, et al.
Publicado: (2018)

Using Xpert MTB/RIF
por: Nicol, Mark P., et al.
Publicado: (2013)

Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
por: Horne, David J, et al.
Publicado: (2019)

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults
por: Kohli, Mikashmi, et al.
Publicado: (2021)

Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children
por: Kay, Alexander W, et al.
Publicado: (2020)

The transition to Xpert MTB/RIF ultra: diagnostic accuracy for pulmonary tuberculosis in Kampala, Uganda
por: Andama, A., et al.
Publicado: (2021)

Comparison of tests done, and tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
por: Kakinda, Michael, et al.
Publicado: (2022)

Impact of Xpert MTB/RIF Testing on Tuberculosis Management and Outcomes in Hospitalized Patients in Uganda
por: Yoon, Christina, et al.
Publicado: (2012)

Evaluation of Cepheid's Xpert MTB/RIF Test on Pleural Fluid in the Diagnosis of Pleural Tuberculosis in a High Prevalence HIV/TB Setting
por: Lusiba, John K., et al.
Publicado: (2014)

Comparison of Analytical Sensitivity (Limit of Detection) of Xpert MTB/RIF and Xpert MTB/RIF Ultra for Non-Sputum Specimens
por: Nielsen, Marisa C., et al.
Publicado: (2023)

Diagnostic accuracy of the Xpert MTB/Rif Ultra for tuberculosis adenitis
por: Antel, Katherine, et al.
Publicado: (2020)

Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey
por: Dorman, Susan E., et al.
Publicado: (2012)

Development of dried tube specimens for Xpert MTB/RIF proficiency testing
por: DeGruy, Kyle, et al.
Publicado: (2020)

Xpert MTB/RIF Ultra versus Xpert MTB/RIF for the diagnosis of tuberculous meningitis: a prospective, randomised, diagnostic accuracy study
por: Donovan, Joseph, et al.
Publicado: (2020)

Correction to: Diagnostic accuracy of the Xpert MTB/Rif Ultra for tuberculosis adenitis
por: Antel, Katherine, et al.
Publicado: (2020)

Expedited diagnosis of pediatric tuberculosis using Truenat MTB-Rif Dx and GeneXpert MTB/RIF
por: Singh, Urvashi B., et al.
Publicado: (2023)

Evaluation of Xpert MTB/RIF for the Diagnosis of Lymphatic Tuberculosis
por: Li, Hou-He, et al.
Publicado: (2020)

Xpert MTB/RIF Ultra versus Xpert MTB/RIF for diagnosis of tuberculous pleural effusion: A systematic review and comparative meta-analysis
por: Aggarwal, Ashutosh Nath, et al.
Publicado: (2022)

Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda
por: Walusimbi, Simon, et al.
Publicado: (2016)

Variation in the observed effect of Xpert MTB/RIF testing for tuberculosis on mortality: A systematic review and analysis of trial design considerations
por: Ochodo, Eleanor A., et al.
Publicado: (2020)

Is aggregated surveillance data a reliable method for constructing tuberculosis care cascades? A secondary data analysis from Uganda
por: White, Elizabeth B., et al.
Publicado: (2022)

Head-to-head comparison of the efficacy of Xpert MTB/RIF Ultra and Xpert MTB/RIF for the diagnosis of tuberculous pleurisy: A systematic review and meta-analysis
por: Yu, Wenfeng, et al.
Publicado: (2022)

Retrospective Diagnostic Accuracy Study of Abbott RealTime MTB against Xpert MTB/RIF Ultra and Xpert MTB/RIF for the Diagnosis of Pulmonary Tuberculosis and Susceptibility to Rifampin and Isoniazid Treatment
por: Howlett, Patrick, et al.
Publicado: (2021)

Evaluation of GeneXpert MTB/RIF for Diagnosis of Tuberculous Meningitis
por: Nhu, Nguyen Thi Quynh, et al.
Publicado: (2014)

Utility of the Xpert MTB/RIF Assay for Diagnosis of Tuberculous Meningitis
por: Boulware, David R.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6lu8tofehfjkgbvspvovbdo1e0